Company Spotlight: Milvue TechCare Trauma - Boosting Fracture Detection by 21.8%

We unpack the FDA's 510(k) summary for Milvue's TechCare Trauma, an AI tool cleared to detect fractures and elbow joint effusions on plain X-rays. Listeners will learn how the software performs across age groups, how its high-sensitivity and high-specificity operating points work, and the results of retrospective clinical studies showing significant jumps in diagnostic sensitivity.

Key points

• TechCare Trauma is a Class II radiological computer-assisted detection software cleared to identify fractures and elbow joint effusions across varying age groups, including neonates.
• In a retrospective clinical study, AI assistance improved reader sensitivity for detecting adult fractures by 21.8%, jumping from 0.807 to 0.983.
• The software uses two distinct operating points: a high-specificity 'YES' output (solid green line) and a high-sensitivity 'DOUBT' output (dotted white line) to manage subtle findings.
• Bench testing utilized massive independent datasets, including 4,109 adult and 2,872 pediatric fracture radiographs, demonstrating consistent ROC-AUC scores of 0.962 for both populations.
• The FDA clearance is based on substantial equivalence to a predicate device, BoneView 1.1-US, though TechCare Trauma notably excludes spine analysis.

Source: FDA 510(k) summary K242171: TechCare Trauma (Milvue) - U.S. Food and Drug Administration, 2025

This episode is an AI-generated conversation summarising a public document; the hosts' voices are synthetic. It is for information only and is not medical advice. Always refer to the original source.

Company: Milvue (milvue.com) · Product: TechCare Trauma · FDA 510(k) K242171

Full transcript: https://ai-in-medicine-podcast.vercel.app/episodes/company-spotlight-milvue-techcare-trauma-boosting-fracture-detection-b-c5043f